Solasia Pharma KK

44
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3436500007
JPY
32.00
1 (3.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Solasia Pharma KK Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,957.00
-1,130.00
-2,489.00
-2,442.00
-4,159.00
-1,797.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-224.00
307.00
-538.00
-524.00
46.00
458.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-1,033.00
-359.00
-2,074.00
-2,473.00
-2,789.00
-828.00
Cash Flow from Investing Activities
0.00
0.00
-418.00
-164.00
-171.00
-735.00
Cash Flow from Financing Activities
1,180.00
275.00
2,571.00
361.00
1,829.00
1,641.00
Net Cash Inflow / Outflow
158.00
-77.00
89.00
-2,251.00
-1,131.00
78.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
11.00
7.00
10.00
25.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Solasia Pharma KK
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-1957
7.456
-1,964.00
-26347.32%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-224
-595.141
371.00
62.36%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-1033
-592.454
-441.00
-74.36%
Cash Flow from Investing Activities
0
-13.498
13.00
100.00%
Cash Flow from Financing Activities
1180
-103.935
1,283.00
1235.32%
Net Cash Inflow / Outflow
158
-709.887
867.00
122.26%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
11
0
11.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -187.74% vs 82.69% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-1,033.00
-359.00
-187.74%